AstraZeneca News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

08.07.20	AstraZeneca: Lynparza Gets EU Approval For BRCA-mutated Metastatic Pancreatic Cancer (RTTNews)
22.06.20	Ascentage Collaborates With Acerta To Evaluate Combination Of Bcl-2 And BTK Inhibitors (RTTNews)
17.06.20	AstraZeneca's Potential Vaccine Likely To Protect Against Covid-19 For A Year : Report (RTTNews)
15.06.20	Catalent Signs Deal With AstraZeneca To Manufacture COVID-19 Vaccine Candidate (RTTNews)
13.06.20	AstraZeneca Inks Contract With Europe's IVA To Supply 400 Mln Doses Of COVID-19 Vaccine (RTTNews)
13.06.20	Race For COVID-19 Vaccine: Who Are The Key Players? (RTTNews)
06.06.20	The Week That Was In COVID: Russia Approves 1st COVID-19 Drug, INO Sues Vaccine Supplier... (RTTNews)
04.06.20	List Of 'Operation Warp Speed' Finalists, SAVA To Reassess AD Study Results; KZR Jumps On MISSION (RTTNews)
01.06.20	FDA Approve AstraZeneca's Brilinta To Reduce Risk Of Stroke In High-risk Patients With CAD (RTTNews)
01.06.20	AstraZeneca: Lynparza Recommended For Marketing Authorisation In EU (RTTNews)
30.05.20	The Week That Was: MRK Enters COVID Space, GSK's 1Bln Dose Target, Roche, GILD Team Up For REMDACTA (RTTNews)
29.05.20	AstraZeneca: IMFINZI Plus Tremelimumab Showed Promising Clinical Activity In HCC Patients (RTTNews)
29.05.20	AstraZeneca Announces Results Of Updated Analysis Of Phase III CASPIAN Trial (RTTNews)
29.05.20	AstraZeneca : Phase II DESTINY-CRC01 Trial Shows Clinically Meaningful Activity In Colorectal Cancer (RTTNews)
29.05.20	AstraZeneca: ADAURA Trial With Tagrisso Shows Improvement In Disease-free Survival (RTTNews)
28.05.20	Oxford Biomedica Signs Deal With AstraZeneca For Manufacture Of COVID-19 Vaccine Candidate (RTTNews)
22.05.20	AstraZeneca: FDA Grants Orphan Drug Designation To Enhertu For Gastric Cancer (RTTNews)
21.05.20	AstraZeneca Receives $1 Bln From U.S. To Produce Oxford's Covid-19 Vaccine (RTTNews)
20.05.20	FDA OKs Myriad's BRACAnalysis CDx Test As Companion Diagnostics For Lynparza (RTTNews)
20.05.20	AstraZeneca: Lynparza Approved In US For HRR Gene-mutated Prostate Cancer (RTTNews)
18.05.20	Enhertu Granted BTD In US For HER2-mutant Metastatic Non-small Cell Lung Cancer (RTTNews)
18.05.20	AstraZeneca: NMPA Approves Bevespi Aerosphere In China For Patients With COPD (RTTNews)
18.05.20	AstraZeneca To Make 30 Mln Doses Of Coronavirus Vaccine By Sept If Successful (RTTNews)
11.05.20	AstraZeneca: FDA Grants Second Breakthrough Therapy Designation To Enhertu (RTTNews)
11.05.20	AstraZeneca Completes Recovery Of Global Rights To Brazikumab From Allergan (RTTNews)
11.05.20	AstraZeneca: FDA Approves Lynparza In Treatment Of HRD-positive Ovarian Cancer (RTTNews)
06.05.20	AstraZeneca Announces Approval Of Farxiga In The US - Quick Facts (RTTNews)
29.04.20	AstraZeneca Q1 Profit Rises; Product Sales Up 15% - Quick Facts (RTTNews)
28.04.20	Biotech Stocks Facing FDA Decision In May 2020 (RTTNews)
27.04.20	AstraZeneca: FDA Approves Label Update For LOKELMA To Include Dosing Guidance (RTTNews)
24.04.20	AZN : Lynparza Shows Overall Survival Benefit In Late-stage Trial On MCRPC (RTTNews)
14.04.20	AstraZeneca To Test Blood Cancer Drug Calquence For Covid-19 Patients (RTTNews)
14.04.20	AstraZeneca To Unblind Tagrisso Phase III ADAURA Trial Early - Quick Facts (RTTNews)
13.04.20	AstraZeneca & Merck Announce FDA Approval Of KOSELUGO - Quick Facts (RTTNews)
30.03.20	AstraZeneca: BRILINTA Reduces Bleeding Complications In Coronary Patients (RTTNews)
30.03.20	AstraZeneca: FDA Approves Imfinzi, Farxiga DAPA-CKD Trial To Be Stopped Early (RTTNews)
26.03.20	AstraZeneca Reports Approval Of Lokelma In Japan For Treatment Of Hyperkalaemia (RTTNews)
19.03.20	AstraZeneca: Lynparza Gets Orphan Drug Designation In Japan (RTTNews)
06.03.20	AstraZeneca: DANUBE Trial For Imfinzi, Tremelimumab Fails To Meet Endpoints (RTTNews)
02.03.20	Biotech Stocks Facing FDA Decision In March 2020 (RTTNews)
25.02.20	AstraZeneca To Sublicense Worldwide Rights To Movantik To RedHill Biopharma (RTTNews)
14.02.20	AstraZeneca FY19 Core Operating Profit Rises; Sales Up 12% - Quick Facts (RTTNews)
28.01.20	Long-term Stocks To Watch: AstraZeneca PLC (AZN) (RTTNews)
27.01.20	AstraZeneca: Brilinta, Enhertu Met Primary Endpoint In Respective Trials (RTTNews)
27.01.20	AstraZeneca To Sell Rights To Hypertension Medicines To Atnahs Pharma (RTTNews)
27.01.20	Allergan To Sell Brazikumab To AstraZeneca, Zenpep To Nestle Under AbbVie Merger (RTTNews)
20.01.20	AstraZeneca: FDA's ODD For Imfinzi, Tremelimumab; Priority Review For Lynparza (RTTNews)
13.01.20	AZN : Lynparza-bevacizumab Granted Priority Review In US For Ovarian Cancer (RTTNews)
06.01.20	AstraZeneca : China Approves Lokelma To Treat Adult Patients With Hyperkalaemia (RTTNews)
31.12.19	ARDS Turning Heads, AXSM's Momentum Continues, SVRA Abuzz, Jiankui Jailed (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	249.90	3.39 %	K V
Sika	203.00	2.63 %	K V
Kuehne+Nagel Int	191.40	2.08 %	K V
Givaudan	3’849.00	1.96 %	K V
Logitech Intl	63.08	1.94 %	K V
Swisscom	538.50	0.37 %	K V
ABB	42.24	0.17 %	K V
Nestle	87.50	0.11 %	K V
Swiss Re	144.65	-0.31 %	K V
Alcon	77.64	-0.38 %	K V

mehr

14.04.25		NASDAQ 100-Papier AstraZeneca-Aktie: Mit dieser Dividende bereitet AstraZeneca Anlegern eine Freude
04.04.25		Verluste in New York: NASDAQ 100 letztendlich tiefrot
04.04.25		Schwache Performance in New York: NASDAQ 100-Anleger bekommen am Freitagnachmittag kalte Füsse
04.04.25		Schwacher Handel in New York: NASDAQ 100 am Mittag mit Kurseinbruch
04.04.25		Freitagshandel in New York: NASDAQ 100 beginnt die Sitzung weit in der Verlustzone
03.04.25		Börse New York: Letztendlich deutlicher Rückschlag für den NASDAQ 100
03.04.25		Schwache Performance in New York: NASDAQ 100 implodiert am Nachmittag
03.04.25		Zurückhaltung in New York: NASDAQ 100 tiefrot

14.04.25

NASDAQ 100-Papier AstraZeneca-Aktie: Mit dieser Dividende bereitet AstraZeneca Anlegern eine Freude

04.04.25

Verluste in New York: NASDAQ 100 letztendlich tiefrot

04.04.25

Schwache Performance in New York: NASDAQ 100-Anleger bekommen am Freitagnachmittag kalte Füsse

04.04.25

Schwacher Handel in New York: NASDAQ 100 am Mittag mit Kurseinbruch

04.04.25

Freitagshandel in New York: NASDAQ 100 beginnt die Sitzung weit in der Verlustzone

03.04.25

Börse New York: Letztendlich deutlicher Rückschlag für den NASDAQ 100